• Top Stories
  • Interviews
  • Business
  • Finance
  • Banking
  • Technology
  • Investing
  • Trading
  • Videos
  • Awards
  • Magazines
  • Headlines
  • Trends
Close Search
00
GBAF LogoGBAF Logo
  • Top Stories
  • Interviews
  • Business
  • Finance
  • Banking
  • Technology
  • Investing
  • Trading
  • Videos
  • Awards
  • Magazines
  • Headlines
  • Trends
GBAF Logo
  • Top Stories
  • Interviews
  • Business
  • Finance
  • Banking
  • Technology
  • Investing
  • Trading
  • Videos
  • Awards
  • Magazines
  • Headlines
  • Trends

Subscribe to our newsletter

Get the latest news and updates from our team.

Global Banking and Finance Review

Global Banking & Finance Review

Company

    GBAF Logo
    • About Us
    • Profile
    • Wealth
    • Privacy & Cookie Policy
    • Terms of Use
    • Contact Us
    • Advertising
    • Submit Post
    • Latest News
    • Research Reports
    • Press Release

    Global Banking & Finance Review® is a leading financial portal and online magazine offering News, Analysis, Opinion, Reviews, Interviews & Videos from the world of Banking, Finance, Business, Trading, Technology, Investing, Brokerage, Foreign Exchange, Tax & Legal, Islamic Finance, Asset & Wealth Management.
    Copyright © 2010-2025 GBAF Publications Ltd - All Rights Reserved.

    ;
    Editorial & Advertiser disclosure

    Global Banking and Finance Review is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

    Finance

    Posted By Global Banking and Finance Review

    Posted on June 23, 2025

    Featured image for article about Finance

    By Sanchayaita Roy, Sukriti Gupta and Pranav Kashyap

    (Reuters) -European stocks stumbled on Monday, as investors nervously eyed the threat of Iranian retaliation following joint U.S.-Israeli strikes on Iran's nuclear sites over the weekend.

    The pan-European STOXX 600 index closed 0.3% lower, after touching its lowest level in over a month earlier in the session.

    Other major bourses also closed in the red, with Germany down 0.3%, France down 0.7%, Britain's FTSE down 0.2%, while Spain's was flat.

    A Reuters report said that Iran could soon strike back at American forces in the Middle East, even as U.S. officials scramble for a diplomatic solution to avert conflict.

    Tensions soared after U.S. warplanes joined Israel in bombing Iran's nuclear facilities over the weekend, prompting Iran to brand President Donald Trump a "gambler" for escalating the standoff.

    With aerial assaults between Israel and Iran showing no sign of slowing, jittery markets braced for the possibility that Iran might retaliate by shutting the Strait of Hormuz—the world's most crucial oil passageway.

    Investors rushed into safe-haven assets, driving up gold prices and eurozone bonds. Meanwhile, the utilities sector, often seen as a bond proxy, outperformed the STOXX 600 sectors.

    Meanwhile, sources said that Germany will raise defence spending to 3.5% of economic output by 2029 funded through a nearly 400 billion euro borrowing programme.

    Still, Europe's aerospace and defence stocks lost 0.7%.

    The U.S. attacks on Iranian nuclear facilities could very well succeed in eliminating a nuclear capable Iran," said David Bahnsen, chief investment officer, The Bahnsen.

    "There is still plenty of risk for short-term volatility driven by the uncertainty of the possibility of Iranian retaliation or a protracted conflict in the region."

    Meanwhile, the July 8 U.S. tariff-pause deadline approaches with little progress on trade deals with Washington, with only a U.S.-UK formal deal reached.

    On the data front, fresh data showed euro zone's economy flat lined for a second month in June, barely expanding, as the bloc's dominant services industry showed only a small sign of improvement and manufacturing displayed none at all.

    Another survey showed British business activity expanded modestly in June.

    The insurance sector lost 1%, dragged by a 4% drop in Munich RE after Morgan Stanley downgraded the stock to "underweight" from "equal weight".

    A near 1% gain in technology stocks kept losses at check.

    Heavyweight Novo Nordisk fell 5.3% after the Danish drugmaker presented full results from two late-stage trials of its experimental weight-loss drug CagriSema

    Spectris rose 15.7% after private equity firm Advent said it will acquire the scientific instruments maker in a deal valued at 4.4 billion pounds ($5.91 billion).

    Holcim gained 14% after the Swiss building materials company completed the spin-off of its North American business Amrize.

    UCB gained 4.4% after Morgan Stanley upgraded the biopharmaceutical company to "overweight" from "equal-weight".

    (Reporting by Sukriti Gupta and Sanchayaita Roy in Bengaluru; Editing by Sherry Jacob-Phillips, Shailesh Kuber and Tasim Zahid)

    Recommended for you

    • Thumbnail for recommended article

    • Thumbnail for recommended article

    • Thumbnail for recommended article

    Why waste money on news and opinions when you can access them for free?

    Take advantage of our newsletter subscription and stay informed on the go!

    Subscribe